Lp-PLA2-IN-13

• UNSPSC Description:

  Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodegenerative related diseases[1].

• Target Antigen:

  Phospholipase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/lp-pla2-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N=C(C2=C(N1CCC3)N3CCO2)OCC4=CC(F)=C(C(F)=C4)OC5=CC(C(F)(F)F)=NC=C5

• Molecular Weight:

  496.39

• References & Citations:

  [1]ZhengHua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. CN113861220A.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2756855-62-4